RBC Europe’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

RBC Europe’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35,000	Closed	-$76.3K	–	1223
2021 Q3	$76.3K	Hold	35,000	–	–	﹤0.01%	478
2021 Q2	$131K	Hold	35,000	–	–	0.01%	380
2021 Q1	$114K	Hold	35,000	–	–	0.01%	383
2020 Q4	$119K	Hold	35,000	–	–	0.01%	357
2020 Q3	$143K	Hold	35,000	–	–	0.01%	302
2020 Q2	$118K	Hold	35,000	–	–	0.01%	303
2020 Q1	$81.5K	Hold	35,000	–	–	0.01%	327
2019 Q4	$127K	Hold	35,000	–	–	0.01%	306
2019 Q3	$290K	Hold	35,000	–	–	0.03%	203
2019 Q2	$301K	Hold	35,000	–	–	0.03%	210
2019 Q1	$374K	Hold	35,000	–	–	0.04%	174
2018 Q4	$306K	Hold	35,000	–	–	0.04%	180
2018 Q3	$588K	Buy	35,000 +10,000	+40%	+$216K	0.07%	146
2018 Q2	$524K	Buy	25,000 +5,000	+25%	+$92.6K	0.06%	153
2018 Q1	$322K	Sell	20,000 -1,200	-6%	-$23.8K	0.04%	200
2017 Q4	$402K	Sell	21,200 -20,000	-49%	-$362K	0.05%	176
2017 Q3	$580K	Buy	+41,200	New	+$373K	0.08%	143

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBC Europe's SPPI Position: Q4 2021 in Review

RBC Europe sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 35,000 shares — an estimated $76.3K sold.

RBC Europe first reported a position in SPPI in Q3 2017 and held it in 17 quarters. The position peaked at $588K in Q3 2018. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.

RBC Europe reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 35,000 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $76.3K.
RBC Europe first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 17 quarters.
RBC Europe's Spectrum Pharmaceuticals Inc position peaked at $588K in Q3 2018.
142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.